Home
Public services
Dashboard
Curated content
Companies
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Companies
Zoticon BioVentures
Save
Zoticon BioVentures
Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular.
Bet Shemesh Jerusalem District (HQ)
http://zoticon.com
B2B
manufacturing
subscription
health
outside tech
cardiology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Related Content
Recent News about Zoticon BioVentures
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Zoticon BioVentures
Edit
Sopherion Therapeutics